These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacokinetic evaluation of fluconazole in critically ill patients. Sinnollareddy M, Peake SL, Roberts MS, Playford EG, Lipman J, Roberts JA. Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033 [Abstract] [Full Text] [Related]
8. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O. J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304 [Abstract] [Full Text] [Related]
11. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Smith J, Andes D. Ther Drug Monit; 2008 Apr; 30(2):167-72. PubMed ID: 18367976 [Abstract] [Full Text] [Related]
15. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J. Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [Abstract] [Full Text] [Related]